Effectdossier · gearchiveerd kwartaal
DNLI
Denali Therapeutics Inc. · Healthcare · Biotechnology
17Gevolgde houders
+1Δ houders
74.76MGehouden aandelen
$1.05BGerapporteerde waarde
+2Nieuwe posities
−1Uitstappen
Momentum-inputs (vergelijkbare managers):
breedte van houders +6.2% ·
aandelenstroom -2.1% ·
netto nieuwe posities +5.9%
— formule
Versnippering van eigendom — meer houders, kleinere totale positie
Alle eigendomscijfers: uitsluitend gevolgde 13F-managers, posities in gewone aandelen, rapportageperiode Q2 2025
Eigendom in de tijd
| Kwartaal | Houders | Δ | Aandelen | Gerapporteerde waarde | Nieuw | Uitstappen |
|---|---|---|---|---|---|---|
| Q2 2026 | 97 | +6 | 103.66M | $2.65B | +11 | −4 |
| Q1 2026 | 93 | +4 | 96.77M | $1.85B | +11 | −8 |
| Q4 2025 | 89 | 0 | 110.68M | $1.83B | +1 | — |
| Q3 2025 | 19 | 0 | 67.26M | $976.61M | — | −1 |
| Q2 2025 | 17 | +1 | 74.76M | $1.05B | +2 | −1 |
| Q1 2025 | 13 | +1 | 44.98M | $611.55M | +2 | −1 |
| Q4 2024 | 12 | -1 | 38.31M | $780.78M | — | −1 |
| Q3 2024 | 12 | 0 | 34.10M | $993.27M | +1 | −1 |
| Q2 2024 | 12 | — | 35.56M | $825.78M | — | — |
Wie het bezit · Q2 2025
| # | Manager | Aandelen | Δ aandelen | Waarde | Hun gewicht | Gehouden | ||
|---|---|---|---|---|---|---|---|---|
| 1 | BlackRock ✦ (passief) | 12.05M | — | $168.63M | 0.0% | n/c | 1 | SEC ↗ |
| 2 | BlackRock ✦ (passief) | 12.05M | — | $168.63M | 0.0% | n/c | 1 | SEC ↗ |
| 3 | BlackRock ✦ (passief) | 12.05M | — | $168.63M | 0.0% | n/c | 1 | SEC ↗ |
| 4 | BlackRock ✦ (passief) | 12.05M | — | $168.63M | 0.0% | n/c | 1 | SEC ↗ |
| 5 | BlackRock ✦ (passief) | 12.05M | — | $168.63M | 0.0% | n/c | 1 | SEC ↗ |
| 6 | BlackRock ✦ (passief) | 12.05M | — | $168.63M | 0.0% | n/c | 1 | SEC ↗ |
| 7 | BlackRock ✦ (passief) | 12.05M | — | $168.63M | 0.0% | n/c | 1 | SEC ↗ |
| 8 | BlackRock ✦ (passief) | 12.05M | — | $168.63M | 0.0% | n/c | 1 | SEC ↗ |
| 9 | BlackRock ✦ (passief) | 12.05M | — | $168.63M | 0.0% | n/c | 1 | SEC ↗ |
| 10 | BlackRock ✦ (passief) | 12.05M | — | $168.63M | 0.0% | n/c | 1 | SEC ↗ |
| 11 | BlackRock ✦ (passief) | 12.05M | — | $168.63M | 0.0% | n/c | 1 | SEC ↗ |
| 12 | BlackRock ✦ (passief) | 12.05M | — | $168.63M | 0.0% | n/c | 1 | SEC ↗ |
| 13 | BlackRock ✦ (passief) | 12.05M | — | $168.63M | 0.0% | n/c | 1 | SEC ↗ |
| 14 | BlackRock ✦ (passief) | 12.05M | — | $168.63M | 0.0% | n/c | 1 | SEC ↗ |
| 15 | BlackRock ✦ (passief) | 12.05M | — | $168.63M | 0.0% | n/c | 1 | SEC ↗ |
| 16 | BlackRock ✦ (passief) | 12.05M | — | $168.63M | 0.0% | n/c | 1 | SEC ↗ |
| 17 | BlackRock ✦ (passief) | 12.05M | — | $168.63M | 0.0% | n/c | 1 | SEC ↗ |
| 18 | Baillie Gifford ✦ | 11.96M | -1.1% | $167.25M | 0.1% | ▼ Trim | 5 | SEC ↗ |
| 19 | Baillie Gifford ✦ | 11.96M | -1.1% | $167.25M | 0.1% | ▼ Trim | 5 | SEC ↗ |
| 20 | Baillie Gifford ✦ | 11.96M | -1.1% | $167.25M | 0.1% | ▼ Trim | 5 | SEC ↗ |
| 21 | Baillie Gifford ✦ | 11.96M | -1.1% | $167.25M | 0.1% | ▼ Trim | 5 | SEC ↗ |
| 22 | The Vanguard Group ✦ (passief) | 11.81M | — | $165.23M | 0.0% | n/c | 1 | SEC ↗ |
| 23 | The Vanguard Group ✦ (passief) | 11.81M | — | $165.23M | 0.0% | n/c | 1 | SEC ↗ |
| 24 | The Vanguard Group ✦ (passief) | 11.81M | — | $165.23M | 0.0% | n/c | 1 | SEC ↗ |
| 25 | The Vanguard Group ✦ (passief) | 11.81M | — | $165.23M | 0.0% | n/c | 1 | SEC ↗ |
| 26 | The Vanguard Group ✦ (passief) | 11.81M | — | $165.23M | 0.0% | n/c | 1 | SEC ↗ |
| 27 | Fidelity (FMR) ✦ | 7.54M | — | $105.46M | 0.0% | n/c | 1 | SEC ↗ |
| 28 | Fidelity (FMR) ✦ | 7.54M | — | $105.46M | 0.0% | n/c | 1 | SEC ↗ |
| 29 | Fidelity (FMR) ✦ | 7.54M | — | $105.46M | 0.0% | n/c | 1 | SEC ↗ |
| 30 | Fidelity (FMR) ✦ | 7.54M | — | $105.46M | 0.0% | n/c | 1 | SEC ↗ |
| 31 | Fidelity (FMR) ✦ | 7.54M | — | $105.46M | 0.0% | n/c | 1 | SEC ↗ |
| 32 | T. Rowe Price ✦ | 6.58M | +50.7% | $92.09M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 33 | T. Rowe Price ✦ | 6.58M | +50.7% | $92.09M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 34 | Wellington Management ✦ | 5.66M | -50.4% | $79.25M | 0.0% | ▼ Trim | 5 | SEC ↗ |
| 35 | Wellington Management ✦ | 5.66M | -50.4% | $79.25M | 0.0% | ▼ Trim | 5 | SEC ↗ |
| 36 | Wellington Management ✦ | 5.66M | -50.4% | $79.25M | 0.0% | ▼ Trim | 5 | SEC ↗ |
| 37 | Wellington Management ✦ | 5.66M | -50.4% | $79.25M | 0.0% | ▼ Trim | 5 | SEC ↗ |
| 38 | Wellington Management ✦ | 5.66M | -50.4% | $79.25M | 0.0% | ▼ Trim | 5 | SEC ↗ |
| 39 | Wellington Management ✦ | 5.66M | -50.4% | $79.25M | 0.0% | ▼ Trim | 5 | SEC ↗ |
| 40 | Wellington Management ✦ | 5.66M | -50.4% | $79.25M | 0.0% | ▼ Trim | 5 | SEC ↗ |
| 41 | State Street Global Advisors ✦ (passief) | 4.52M | +1.3% | $63.21M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 42 | Norges Bank ✦ (passief) | 3.95M | +29.5% | $55.22M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 43 | Geode Capital Management ✦ (passief) | 3.17M | +4.5% | $44.39M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 44 | Geode Capital Management ✦ (passief) | 3.17M | +4.5% | $44.39M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 45 | Point72 Asset Management ✦ | 2.21M | Nieuw | $30.97M | 0.1% | New | 1 | SEC ↗ |
| 46 | Fisher Asset Management ✦ | 1.52M | +11.1% | $21.21M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 47 | Marshall Wace ✦ | 1.41M | -35.8% | $19.66M | 0.0% | ▼ Trim | 5 | SEC ↗ |
| 48 | Citadel Advisors ✦ | 1.25M | +6.8% | $17.47M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 49 | Citadel Advisors ✦ | 1.25M | +6.8% | $17.47M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 50 | Millennium Management ✦ | 900.50K | -39.7% | $12.60M | 0.0% | ▼ Trim | 5 | SEC ↗ |
| 51 | Renaissance Technologies ✦ | 195.70K | +13.1% | $2.74M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 52 | AQR Capital Management ✦ | 21.22K | Nieuw | $296,825 | 0.0% | New | 1 | SEC ↗ |
| 53 | AQR Capital Management ✦ | 21.22K | Nieuw | $296,825 | 0.0% | New | 1 | SEC ↗ |
| 54 | AQR Capital Management ✦ | 21.22K | Nieuw | $296,825 | 0.0% | New | 1 | SEC ↗ |
| 55 | Two Sigma Investments ✦ | 19.30K | -81.2% | $270,007 | 0.0% | ▼ Trim | 5 | SEC ↗ |
"Hun gewicht" = het aandeel van de positie in de gerapporteerde 13F-aandelenwaarde van die beheerder — de overtuigingsmaatstaf. ✦ = gecureerde beheerder.
Nieuwe kopers
| Point72 Asset Management | $30.97M | 0.1% |
| AQR Capital Management | $296,825 | 0.0% |
| AQR Capital Management | $296,825 | 0.0% |
| AQR Capital Management | $296,825 | 0.0% |
Verlaten
| D. E. Shaw & Co. | $1.06M | was 0.0% |
Volledige marktcontext: over ALLE 13F-indieners (SEC gestructureerde data, Q1 2026): 265 houders, 147.10M aandelen, $2.60B gerapporteerd. Dit betreft een andere, oudere periode dan de bovenstaande cijfers van het gevolgde universum; beide worden nooit gecombineerd.
Vaak gezamenlijk in bezit
Wat de gevolgde houders van dit effect verder het vaakst bezitten — aantallen gedeeld eigendom, geen fundamentele relaties.
Open-market aankopen (P)
Geen open-market insider-aankopen in ons dekkingsvenster.
Open-market verkopen (S)
Aug 11
Schuth Alexander O.
Officer · 2.86K aand · $71,625
Toekenningen, uitoefeningen en belastinginhoudingen worden hier nooit meegeteld als aankopen of verkopen. Methodologie
Aug 04
SC 13G/A — BAILLIE GIFFORD & CO
Jul 08
SC 13G/A — T. Rowe Price Investment Management…
Herkomst: Eigendom op basis van geparseerde 13F common-stockposities (gevolgde universum, vergelijkbare sets voor wijzigingen); insider-rijen afkomstig van formulieren 3/4/5; belangen uit Schedules 13D/13G; elke indiening verwijst naar het origineel op SEC EDGAR.
Rapportageperiode: Q2 2025 ·
Methodologie ·
Verkrijg dit via de API